InsiderTrades

Form 4 for SLDB Solid Biosciences Inc.

Accepted 2025-12-04 00:00:00 ET · period of report 2025-12-02 · accession 0001193125-25-308103 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2025-12-04 2025-12-02 SLDB Herzich Paul CTO M - OptEx — +7,239 29.3K +33% —
DT 2025-12-04 2025-12-03 SLDB Herzich Paul CTO S - Sale+OE $5.11 -2,701 26.6K -9% -$13.8K
DT 2025-12-04 2025-12-02 SLDB Herzich Paul CTO M - OptEx $0.00 -7,239 7,239 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-02 M A 7,239 — 29,323 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). (F2) Includes 1,835 and 1,861 shares of the issuer's common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 30, 2025 and November 28, 2025, respectively.
2 Common Common Stock 2025-12-03 S D 2,701 $5.11 26,622 D — — (F3) This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Herzich on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Herzich
3 Derivative Restricted Stock Units 2025-12-02 M D 7,239 $0.00 7,239 D — · — to — 7,239 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). (F4) The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.